Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Carasent

24.5

 

SEK

 

-1.21 %

1,659 following

CARA

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
-1.21%
+8.43%
+3.81%
+10.36%
+28.72%
+33.53%
+23.93%
+59.05%
+10.77%

Carasent is an IT company. The company delivers a wide range of products and services in communication and IT infrastructure specifically aimed at the healthcare industry. Examples of solutions include proprietary cloud-based services, email management, mobile solutions, and security solutions. Customers are mainly found in health and care, finance, and telecom. The company was originally established in 1997 and is headquartered in Gothenburg.

Read more
Market cap
1.77B SEK
Turnover
1.03M SEK
Revenue
267.75M
EBIT %
-19.8 %
P/E
-
Dividend yield-%
-
Financial calendar
10/7
2025

Interim report Q2'25

16/10
2025

Interim report Q3'25

12/2
2026

Annual report '25

All
Webcasts
Press releases
ShowingAll content types
Regulatory press release4/23/2025, 1:12 PM

Annual General Meeting in Carasent AB (publ)

Carasent
Regulatory press release4/23/2025, 1:12 PM

Årsstämma i Carasent AB (publ)

Carasent
Press release4/14/2025, 2:08 PM

Redeye: Carasent - AI initiatives in focus

Carasent

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release4/14/2025, 5:10 AM

Carnegie Access: Carasent: Solid start to the year – Q1 review

Carasent
Press release4/11/2025, 8:01 AM

Carnegie Access: Carasent: Strong growth in Q1 – initial comment

Carasent
Carasent, Audiocast with teleconference, Q1'25
Webcast4/11/2025, 6:00 AM

Carasent, Audiocast with teleconference, Q1'25

Carasent
Regulatory press release4/11/2025, 5:00 AM

Carasent AB (publ) – interim report Q1 2025

Carasent
Regulatory press release4/11/2025, 5:00 AM

Carasent AB (publ) – delårsrapport januari – mars 2025

Carasent
Regulatory press release4/7/2025, 1:30 PM

Carasent AB (publ) – Invitation to presentation of Q1 2025 results

Carasent
Regulatory press release4/7/2025, 1:30 PM

Carasent AB (publ) – Inbjudan till presentation av det första kvartalet 2025

Carasent
Press release4/2/2025, 3:54 PM

Carnegie Access: Carasent: The scene is set for 2025 – Q1 preview

Carasent
Press release3/31/2025, 8:01 AM

Carnegie Access: Analyspodden 326: Carasent & Carnegies analytiker Elvin Rolder

Carasent
Regulatory press release3/24/2025, 4:00 PM

Carasent publishes Annual Report for 2024

Carasent
Regulatory press release3/24/2025, 4:00 PM

Carasent publicerar årsredovisning för 2024

Carasent
Regulatory press release3/24/2025, 7:00 AM

Notice of Annual General Meeting in Carasent AB (publ)

Carasent
Regulatory press release3/24/2025, 7:00 AM

Kallelse till årsstämma i Carasent AB (publ)

Carasent
Press release3/21/2025, 12:05 PM

The Administrative Court rejects the healthcare providers' appeal to remove the requirement for Millennium in primary care in VGR

Carasent
Press release3/21/2025, 12:05 PM

Förvaltningsrätten avslår vårdgivarnas ansökan om överprövning av kravet på Millennium i primärvården i VGR

Carasent
Press release3/12/2025, 5:17 AM

Carnegie Access: Carasent: Impressions from Carnegie’s Healthcare Conference

Carasent
Regulatory press release2/21/2025, 12:08 PM

Proposal for election of the board of Carasent AB (publ)

Carasent
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team